[Proceedings: Electron microscopy studies on the absorption of proteins from the endolymph].

PubWeight™: 0.80‹?›

🔗 View Article (PMID 4785490)

Published in Arch Klin Exp Ohren Nasen Kehlkopfheilkd on December 17, 1973

Authors

K Jahnke, H Rudert

Articles citing this

Macromolecular transport in the spiral prominence. Arch Otorhinolaryngol (1982) 0.81

Articles by these authors

(truncated to the top 100)

An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum (2000) 3.06

E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res (1991) 2.67

[Iatrogenic injury of the internal carotid artery in adenectomy]. Laryngorhinootologie (2013) 1.98

Cemento-ossifying fibroma of the petromastoid region: case report and review of the literature. J Laryngol Otol (1997) 1.72

Expression of the gap-junction connexins 26 and 30 in the rat cochlea. Cell Tissue Res (1998) 1.58

The fine structure of freeze-fractured intercellular junctions in the guinea pig inner ear. Acta Otolaryngol Suppl (1975) 1.51

Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol (2007) 1.47

Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology (2008) 1.44

[Ambulatory rehabilitation after cochlear prosthesis implantation]. HNO (2000) 1.40

[Osteosynthesis in facial bones: silicon nitride ceramic as material]. HNO (2006) 1.39

[Reconstruction of the superstructure of the stapes in guinea pigs with biovitro ceramic and silicone foil]. HNO (2002) 1.38

Prospective trial on topotecan salvage therapy in primary CNS lymphoma. Ann Oncol (2006) 1.17

Demonstration of identical clonal derivation in a case of "oculocerebral" lymphoma. Br J Ophthalmol (2005) 1.16

[Clinical studies on the effect of a new oral antidiabetic agent Glybenclamide (HB 419)]. Dtsch Med Wochenschr (1969) 1.15

Mutations in the connexin26/GJB2 gene are the most common event in non-syndromic hearing loss among the German population. Hum Mutat (2001) 1.12

Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer (2000) 1.12

[Surgical treatment of auditory canal exostoses]. Laryngorhinootologie (1999) 1.10

Developmental expression patterns of connexin26 and -30 in the rat cochlea. Dev Genet (1999) 1.09

[Investigations on the vestibular recruitment (author's transl)]. Laryngol Rhinol Otol (Stuttg) (1975) 1.01

Effects of noise on speech discrimination in cochlear implant patients. Ann Otol Rhinol Laryngol Suppl (1995) 0.98

[Lymphatic metastases of verrucous carcinoma (Ackerman tumor)]. HNO (1987) 0.97

[Intercellular junctions in the guinea pig stria vascularis as shown by freeze-etching (author's transl)]. Anat Embryol (Berl) (1975) 0.97

[Prosthetic supply of tissue defects in head and neck surgery]. Laryngorhinootologie (2007) 0.96

PYD2 encodes 5,6-dihydropyrimidine amidohydrolase, which participates in a novel fungal catabolic pathway. J Mol Biol (2000) 0.96

Functional results following partial supraglottic resection. Comparison of conventional surgery vs. transoral laser microsurgery. Adv Otorhinolaryngol (1995) 0.95

[Investigation on resorption of the endolymph in the inner ear of the guinea pig. II. Experiments with radioactive labeled substances and autoradiographic evaluation]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1969) 0.93

[Fine structural studies on the permeability barriers of the inner ear (author's transl)]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1973) 0.92

p53 serum antibodies as prognostic indicator in head and neck cancer. Cancer Immunol Immunother (1997) 0.92

Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease. QJM (1996) 0.90

Comparative investigation of the biocompatibility of various silicon nitride ceramic qualities in vitro. J Mater Sci Mater Med (2004) 0.90

Vascular variations of the inner ear. Acta Otolaryngol (2001) 0.90

Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus. Oncology (1999) 0.90

Ultrasound-guided interstitial Nd: YAG laser treatment of voluminous hemangiomas and vascular malformations in 92 patients. Laryngoscope (1998) 0.89

[Investigation on resorption of the endolymph in the inner ear of the guinea pig. 3. Electron microscope investigations on the structure of the endolymphatic sac and ferritin resorption in the membranous labyrinth]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1969) 0.88

The blood-perilymph barrier. Arch Otorhinolaryngol (1980) 0.87

Description and clinical importance of the lymphatics of the vocal fold. Otolaryngol Head Neck Surg (1990) 0.86

Lipoma of the larynx. Report of 2 cases and review of the literature. Otolaryngol Pol (2002) 0.86

[Sudden deafness caused by rupture of the round window membrane. Surgical indications, course and prognosis]. HNO (1986) 0.85

The permeability of blood vessels in the guinea pig cochlea. I. Vessels of the modiolus and spiral vessel. Anat Embryol (Berl) (1974) 0.85

[Patients' satisfaction after nasal septal and turbinate surgery. Results of a questionnaire]. Laryngorhinootologie (2007) 0.84

[Ambulatory surgery in the otorhinolaryngology, head and neck surgery specialty--combined scientific medical position of the German Society of Otorhinolaryngology, Head and Neck Surgery e.V., the German Professional Society of Otorhinolaryngologists e.V. and the Working Group of ENT Directors]. Laryngorhinootologie (2000) 0.84

Primary orbital leiomyoma and leiomyosarcoma. Ophthalmologica (1999) 0.84

[Golden tube wire for temporary or permanent implantation]. HNO (1996) 0.84

[Mucormycosis in paranasal sinuses]. HNO (2009) 0.83

Organ-limited laryngeal amyloid deposits: clinical, morphological, and immunohistochemical results of five cases. Ann Otol Rhinol Laryngol (1992) 0.83

Acid base catalytic mechanism of the dihydropyrimidine dehydrogenase from pH studies. J Biol Chem (1993) 0.83

[Aminoglycoside- and cisplatin-ototoxicity: from basic science to clinics]. Laryngorhinootologie (2004) 0.83

[First experiences with voice-rehabilitative laryngectomy, as described by Staffieri and Amatsu (author's transl)]. Laryngol Rhinol Otol (Stuttg) (1979) 0.83

[Investigation on resorption of the endolymph in the inner ear of the guinea pig. I. Microscopic examinations after injection of trypan blue into the cochlear duct]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1969) 0.83

Tracing human papillomavirus DNA in nasal polyps by polymerase chain reaction. Acta Otolaryngol (2000) 0.83

[Animal experiment studies of laser effects on lymphatic vessels. A contribution to the discussion of laser surgery segmental resection of carcinomas]. Laryngorhinootologie (1995) 0.82

E-cadherin as a functional marker of the differentiation and invasiveness of squamous cell carcinoma of the head and neck. Clin Otolaryngol Allied Sci (1994) 0.82

Does metal coating improve the durability of silicone voice prostheses? Acta Otolaryngol (2001) 0.82

The permeability of blood vessels in the guinea pig cochlea. II. Vessels in the spiral ligament and the stria vascularis. Anat Embryol (Berl) (1974) 0.82

[Acute isolated vestibular paralysis. A clinical and electronystagmographic follow-up study in 28 patients]. HNO (1977) 0.82

[Cutaneous basosquamous cell carcinoma]. HNO (2008) 0.82

[The fine structure of the subfornical organ in the rabbit. II. The neuronal and flial tissues]. Z Zellforsch Mikrosk Anat (1968) 0.82

[Biocompatibilty of silicon nitride ceramic in vitro. A comparative fluorescence-microscopic and scanning electron-microscopic study]. Laryngorhinootologie (2004) 0.82

[Treatment of recurrent epistaxis in Rendu-Osler-Weber disease]. HNO (1997) 0.81

[Electron microscopic study on the resorption of the endolymph in the middle ear of the guinea pig]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1968) 0.81

[Corrosive injuries of the oesophagus (report of 138 cases with follow-up of 46 cases (author's transl)]. Laryngol Rhinol Otol (Stuttg) (1974) 0.81

[Meniere disease as an autosome dominant hereditary disease]. Laryngorhinootologie (1995) 0.81

[The pathogenesis of the acute symptoms of Menière's disease (author's transl)]. Laryngol Rhinol Otol (Stuttg) (1977) 0.81

Neomycin as secondary prophylaxis for irinotecan-induced diarrhea. Ann Oncol (2004) 0.81

[Investigations of carbohydrate and fat metabolism in pre-diabetes]. Diabetologia (1968) 0.81

[Smoking promotes the formation of peritonsillar abscesses]. Laryngorhinootologie (2005) 0.81

[Long-term results of laser-tonsillotomy in obstructive tonsillar hyperplasia]. Laryngorhinootologie (2004) 0.80

Freeze-fracture studies on the perilymph-endolymph barrier in experimentally induced hydrops. Arch Otorhinolaryngol (1985) 0.80

[Hyperfractionated accelerated simultaneous radiochemotherapy in advanced hypopharyngeal carcinomas. Survival rate, retained function quality of life in a phase II study]. HNO (1998) 0.80

[Light microscopic studies on the crista ampullaris of the guinea pig labyrinth]. Z Zellforsch Mikrosk Anat (1966) 0.80

[Progress in microsurgery of the middle ear]. HNO (1987) 0.80

[Hypacusis in acquired hypothyroidism (author's transl)]. HNO (1979) 0.80

Primary papillary carcinoma of the thyroglossal duct: case report and review of the literature. Auris Nasus Larynx (1994) 0.80

Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to topotecan. Neurology (2004) 0.79

Nd: YAG laser therapy of voluminous hemangiomas and vascular malformations. Adv Otorhinolaryngol (1995) 0.79

Chemo-radiotherapy for locally advanced head and neck cancer--long-term results of a phase II trial. Eur J Cancer (1997) 0.79

[Influence of weight reduction on carbohydrate and fat metabolism and on serum insulin response in obesity]. Diabetologia (1968) 0.79

[Permeability barriers of the inner ear. Fine structure and function]. Fortschr Med (1980) 0.79

Cyfra 21-1: a serological help for detection of distant metastases in head and neck cancer. Anticancer Res (2000) 0.79

[Giant cell tumor of the larynx]. HNO (1971) 0.79

[Concepts for measuring quality of life in patients with chronic sinusitis]. Laryngorhinootologie (1999) 0.79

Serum p53 autoantibodies in the follow-up of head and neck cancer patients. Oncology (2000) 0.78

[Distribution of intrathecally administered peroxidase in the guinea pig cochlea]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1972) 0.78

Purification and characterization of dihydropyrimidine dehydrogenase from Alcaligenes eutrophus. Arch Biochem Biophys (1996) 0.78

Porcine recombinant dihydropyrimidine dehydrogenase: comparison of the spectroscopic and catalytic properties of the wild-type and C671A mutant enzymes. Biochemistry (1998) 0.78

[Critical evaluation of vascular embolization in patients with Rendu-Osler disease]. Laryngorhinootologie (1997) 0.78

Transcriptional repression of the human galactocerebrosidase gene in squamous cell carcinomas of the larynx. Int J Cancer (1999) 0.78

p53 analysis of laryngeal cancer in exon 4 to 9. Anticancer Res (2000) 0.78

Indication, incidence and management of blood transfusion during sinus surgery: a review over 12 years. Rhinology (1997) 0.78

Purification, characterization, and kinetics of porcine recombinant dihydropyrimidine dehydrogenase. Protein Expr Purif (1997) 0.78

[Laser-tonsillotomy, state of the art and open questions]. Laryngorhinootologie (2005) 0.78

Experimental and clinical results of Er:YAG laser stapedotomy. Lasers Surg Med (2001) 0.77

Transcriptional repression of the human fibronectin gene in laryngeal squamous cell carcinoma cells. J Cancer Res Clin Oncol (2001) 0.77

Coincidence of normal tension glaucoma, progressive sensorineural hearing loss, and elevated antiphosphatidylserine antibodies. Br J Ophthalmol (2004) 0.77

Extrusion of middle ear implants. Clin Otolaryngol Allied Sci (1987) 0.77

Biocompatibility testing of new polymers in a moving implant bed. ORL J Otorhinolaryngol Relat Spec (2000) 0.77

[Introduction of interdisciplinary prostate cancer centers based on the recommendations of the German Cancer Society. A cost-benefit analysis 3 years after accreditation]. Urologe A (2011) 0.77

[Manifestations of primary vasculitis in the ENT region]. Z Rheumatol (2001) 0.77

Expression of a novel mRNA in human head and neck squamous cell carcinoma cells. Mol Pathol (1997) 0.77

Effects of norepinephrine, theophylline and dibutyryl cyclic AMP on in vitro lipolysis of human adipose tissue in obesity. Diabetologia (1972) 0.77